Harmony Biosciences Holdings (HRMY) Other Working Capital Changes (2019 - 2026)

Harmony Biosciences Holdings' (HRMY) quarterly Other Working Capital Changes came in at $3.0 million in Q1 2026, up 49.87% year-on-year from $2.0 million in Q1 2025, and up 112.06% quarter-over-quarter from -$24.8 million in Q4 2025.

Harmony Biosciences Holdings (HRMY) Other Working Capital Changes (2019 - 2026) Analysis & Trends

Harmony Biosciences Holdings has disclosed Other Working Capital Changes across 8 years of filings, most recently posting $3.0 million for Q1 2026.

  • Other Working Capital Changes for Q1 2026 came in at $3.0 million, up 49.87% year-over-year; the trailing twelve-month figure through Mar 2026 was -$30.8 million (down 2063.65% YoY), and the FY2025 annual result was -$31.8 million, down 1156.75% from the prior year.
  • Other Working Capital Changes came in at $3.0 million for Q1 2026 at Harmony Biosciences Holdings, up from -$24.8 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $7.7 million in Q4 2022 to a low of -$24.8 million in Q4 2025.
  • The 5-year median for Other Working Capital Changes is $565000.0 (2024), against an average of -$1.1 million.
  • Peak annual rise in Other Working Capital Changes reached 4852.47% in 2022, while the deepest fall reached 7379.25% in 2022.
  • Harmony Biosciences Holdings' Other Working Capital Changes stood at $7.7 million in 2022, then tumbled by 123.81% to -$1.8 million in 2023, then decreased by 0.55% to -$1.8 million in 2024, then slumped by 1248.07% to -$24.8 million in 2025, then jumped by 112.06% to $3.0 million in 2026.
  • The last three Other Working Capital Changes figures came in at $3.0 million (Q1 2026), -$24.8 million (Q4 2025), and -$12.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Harmony Biosciences Holdings 1.92 Bn 1.28 Bn 170.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.00 Mn
Mar 31, 2026 3.00 Mn
Dec 31, 2025 -24.85 Mn
Dec 31, 2025 -24.85 Mn
Sep 30, 2025 -12.53 Mn
Sep 30, 2025 -12.53 Mn
Jun 30, 2025 3.59 Mn
Jun 30, 2025 3.59 Mn
Mar 31, 2025 2.00 Mn
Mar 31, 2025 2.00 Mn
Dec 31, 2024 -1.84 Mn
Dec 31, 2024 -1.84 Mn
Sep 30, 2024 847,000.00
Sep 30, 2024 847,000.00
Jun 30, 2024 565,000.00
Jun 30, 2024 565,000.00
Mar 31, 2024 3.44 Mn
Mar 31, 2024 3.44 Mn
Dec 31, 2023 -1.83 Mn
Dec 31, 2023 -1.83 Mn